Apollo Endosurgery to Present at The LD 500 Virtual Conference
Apollo Endosurgery (NASDAQ:APEN) will present at the LD 500 investor conference on September 2, 2020, at 11:40 AM ET. CEO Todd Newton and CFO Stefanie Cavanaugh will address a live virtual audience and conduct investor meetings throughout the day. Interested participants can register at LD Micro. Apollo specializes in less invasive medical devices for gastrointestinal and bariatric procedures, with products available in over 75 countries, including the OverStitch™ and ORBERA® systems. For more details, visit Apollo Endosurgery.
- None.
- None.
LOS ANGELES, CA / ACCESSWIRE / August 26, 2020 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced that it will present at the LD 500 investor conference on Wednesday, September 2 at 11:40 AM Eastern Time. Todd Newton, CEO, and Stefanie Cavanaugh, CFO, will be presenting to a live virtual audience and available for investor meetings throughout the day.
Investors interested in attending the presentation can register online at https://ld500.ldmicro.com/ to join the group presentation session. A free profile for APEN is available at http://www.ldmicro.com/profile/APEN. Institutional and other qualified investors may request one-on-one meetings via LD Micro if they have an existing relationship, or by contacting APEN's investor relations, Matt Kreps of Darrow Associates, at mkreps@darrowir.com.
About Apollo Endosurgery, Inc.
Apollo Endosurgery, Inc. is a medical technology company focused on less invasive therapies to treat various gastrointestinal conditions, ranging from gastrointestinal complications to the treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 75 countries today and include the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, and the ORBERA® Intragastric Balloon.
Apollo's common stock is traded on the Nasdaq Global Market under the symbol "APEN". For more information regarding Apollo Endosurgery, go to: www.apolloendo.com.
About LD Micro
Back in 2006, LD Micro began with the sole purpose of being an independent resource to the microcap world.
What started as a newsletter highlighting unique companies, has transformed into the pre-eminent event platform in the space.
The upcoming "500" in September is the Company's most ambitious project yet, and the first event that is accessible to everyone.
For those interested in attending, please contact David Scher at david@ldmicro.com or visit www.ldmicro.com for more information.
Contacts:
Apollo Endosurgery, Inc.
Stefanie Cavanaugh, 512-279-5100
investor-relations@apolloendo.com
Darrow Associates Investor Relations
Matt Kreps, 214-597-8200
mkreps@darrowir.com
SOURCE: Apollo Endosurgery, Inc. via LD Micro
View source version on accesswire.com:
https://www.accesswire.com/603470/Apollo-Endosurgery-to-Present-at-The-LD-500-Virtual-Conference
FAQ
When is Apollo Endosurgery presenting at the LD 500 conference?
Who will represent Apollo Endosurgery at the LD 500 conference?
How can investors register for the LD 500 conference?
What products does Apollo Endosurgery offer?
In how many countries are Apollo's products available?
